Last updated on November 2018

Tirofiban for Patients Treated With Alteplase


Brief description of study

After intravenous thrombolysis, the overall recanalization rate is 46%, and recclusion after initial recanalization occurs in 14-34%. In the MR TEA, the investigators compared the effects of administration of tirofiban in acute ischemic stroke patients treated with intravenous alteplase thrombolysis with alteplase alone.

Clinical Study Identifier: NCT03357133

Contact Investigators or Research Sites near you

Start Over

Zhengfei Ma, MD

Suzhou Municipal Hoapital
Suzhou, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.